HelixNews
LatestWeekLocalBlindspot

2 sources covering

GLP-1 users face 6 rebound risks after stopping the weight-loss drugs

NY Post ·

While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.

Read at NY Post

Who's covering it

Order

First reported by Fox News at · 2 outlets in all

Filter by type, country or lean
By type
Country
Lean
  1. NY PostGLP-1 users face 6 rebound risks after stopping the weight-loss drugsWhile GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.
  2. Fox NewsOzempic and Zepbound users face 6 rebound risks after stopping, doctor warnsThinking of quitting a GLP-1? A physician outlines six risks, from weight regain and muscle loss to worsening biomarkers and mental health consequences.